The DEA seized hemp seeds that were destined for research programs in Kentucky.
Earlier this month, the DEA seized a 250-lb shipment of imported Italian hemp seeds. The seeds were bound for Kentucky, which is allowed to research hemp thanks to a hemp provision in the new Farm Bill.
Kentucky’s Department of Agriculture (which ordered the hemp) filed suit with the DEA on Wednesday, and today a federal judge held a hearing in Louisville to determine if the DEA has any right to interfere with Kentucky’s research.
The Lexington Herald-Leader reports from the hearing that assistant U.S. attorney Ben Schecter said that Kentucky will get its seeds back if it applies for a controlled-substance import permit. “He suggested that the DEA would be ‘partners rather than adversaries in this,” wrote the Lexington Herald-Leader. But Kentucky’s Department of Agriculture sounds as if they will only comply with the permit if the DEA allows its department and partnering universities to work with private Kentucky growers-presumably to wane itself of these tricky imports in the future.
The judge presiding over the case asked the Department to prepare details of its terms so that the DEA can sign off on them. It sounds like the Department is going to do so immediately, so that the judge can hold a formal review next Wednesday, May 21.
Kentucky is one of several states preparing to grow local hemp. Right now, states that have passed pro-cultivation laws can only grow the plant for research purposes through pilot programs tied to academic institutions and state departments of agriculture.
Here’s a helpful resource for knowing which U.S. states can grow hemp.
Robby Gardner
â¨Associate Editorâ¨
Nutritional Outlook magazine
â¨robby.gardner@ubm.com
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.